MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UK-05-0004318
Cris Pharma (India) Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹55.24 Cr
▼ 4% YoY
Net profit · FY 2024
₹2.8 Cr
Net margin 5.1%
EBITDA · FY 2024
₹5.13 Cr
EBITDA margin 9.3%
Authorised capital
₹1.25 Cr
Registered with MCA
Paid-up capital
₹1.24 Cr
Issued & subscribed
Open charges
₹3.52 Cr
Satisfied ₹8.13 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
161
Provident fund records
About Cris Pharma (India) Limited
Data last updated:
Cris Pharma (India) Limited is a public limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 September 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24139RJ1992PLC034757. Its GSTIN is 05AAACC8431A1ZB (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.24 Cr. It is led by directors including Poonam Chand Taparia (Whole-Time Director) and Kailash Chand Melana.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sp – 2 22 Godam Industrial Estate, Jaipur, Rajasthan, India – 302006.
As per the financials filed for FY 2024, the company reported a revenue of ₹55.24 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2.8 Cr (net margin 5.1%) and EBITDA of ₹5.13 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 13% over five years.
The company has about 161 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Cris Pharma. As per MCA filings, the company has open charges of ₹3.52 Cr and satisfied charges of ₹8.13 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 2 cases are pending.
Cris Pharma (India) Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0004318). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website crispharma.com.
Company details
CIN U24139RJ1992PLC034757
Registration Number 034757
Incorporation Date 01 September 1992
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UK-05-0004318
CIN history
Cris Pharma (India) has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24139RJ1992PLC034757, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24139RJ1992PLC034757 | Current |
| U24139MH1992PLC068365 | Previous |
| U24139MH1992PTC068365 | Previous |
Key People
Poonam Chand Taparia Whole-Time Director Kailash Chand Melana Director Suwa Lal Jat Director Recognitions & Rankings of Cris Pharma (India)
Contact details
Cris Pharma (India) Limited's registered office is in Jaipur, Rajasthan. Its website is crispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSp – 2 22 Godam Industrial Estate, Jaipur, Rajasthan, India – 302006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cris Pharma (India) Limited, buy the company report.
Comprehensive company report
Cris Pharma (India) Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cris Pharma (India) operates one associated brand: Cris Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in contract manufacturing of tablets, liquid orals, capsules, and powders. | crispharma.com |
Business activity
The main business activity of Cris Pharma (India) is agriculture, forestry, fishing. In detail, this covers support activities to agriculture and other activities including hunting.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting |
To see the full business activity and turnover split of Cris Pharma (India) Limited, buy the company report.
Financials of Cris Pharma (India) Limited
FY 2024 filings availableCris Pharma (India) Limited reported revenue of ₹55.24 Cr (down 4% YoY) for FY 2024.
Revenue · FY 2024
₹55.24 Cr ▼ 4%
Net profit · FY 2024
₹2.8 Cr margin 5.1%
EBITDA · FY 2024
₹5.13 Cr margin 9.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 12%
5 years · compounded
▲ 13%
EBITDA CAGR growth
3 years · compounded
▼ 1%
5 years · compounded
▲ 7%
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cris Pharma (India) Limited, buy the company report.
Board of directors of Cris Pharma (India) Limited
Cris Pharma (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Chand Taparia | Whole-Time Director | 25 Aug 1997 | 29 Years 2 Months | Current |
| Kailash Chand Melana | Director | 20 Mar 2005 | 21 Years 7 Months | Current |
| Suwa Lal Jat Also directs: Novelsort Lifecare Private Limited | Director | 25 Jul 2011 | 15 Years 3 Months | Current |
Auditor
Cris Pharma (India) Limited is audited by Kalani & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kalani & Company | FY 2023 | 000722C |
Shareholding
The shareholding of Cris Pharma (India) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cris Pharma (India) Limited, buy the company report.
Charges & borrowings
Open charges
₹3.52 Cr
Satisfied charges
₹8.13 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2021 | 100428021 | Sidbi | ₹50 Lakh | Open | |
| 16 Nov 2017 | 100171676 | Others | ₹3.02 Cr | Open | |
| 30 Jul 2014 | 10513388 | Hdfc Bank Limited | ₹2.4 Cr | Satisfied | |
| 13 Feb 2013 | 10414270 | State Bank of India | ₹90 Lakh | Satisfied | |
| 30 Mar 2011 | 10275917 | Small Industrial Development Bank of India | ₹1 Cr | Satisfied |
To see the full charge records of Cris Pharma (India) Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Cris Pharma (India) Limited has 7 court cases on record: 1 filed by Cris Pharma (India), 6 filed against it. 2 cases are pending and 5 are disposed.
Total cases
7
Filed by the company
1
Filed against the company
6
Pending
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
| High courts | 3 | 2 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Jharkhand | Court case (Cr.M.P.) | Filed by the company against M/S Seagull Pharmaceuticals Pvt Ltd, Through Its Authorized Representative Sameer Bhatnagar and 1 other | Pending |
| Bombay High Court | Court case (S) | Filed against the company by Lupin Ltd. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Lupin Ltd. | Disposed |
| District court, Suryapet, Telangana | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Cris Pharma (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Cris Pharma (India) Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 279 overdue payments to 36 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 36)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Oasis Test House Limited | |||
| S. K. Industries | |||
| Pro Packaging Industries | |||
| an individual supplier | |||
| Sky Pharmaceuticals, Thane |
To see the full MSME payment records of Cris Pharma (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cris Pharma (India) Limited has a workforce of 161 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.
Employee count
161
Active EPFO establishments
1
Employee growth
-4.17%
GST
Cris Pharma (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACC8431A1ZB | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cris Pharma (India) Limited, buy the company report.
Recent activity
Cris Pharma (India) Limited has 8 board changes on record since 1997: 3 appointments and 5 cessations. The latest: Rajnikant Chunilal Mehta ceased to be Director on 17 Apr 2023.
Charges
A charge with Others of Rs. 3.02 Cr registered on 16 Nov 2017 with Charge ID 100171676 was modified on 29 May 2025.
AGM
Cris Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Cris Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
Ceased
Rajnikant Chunilal Mehta ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100428021 was registered on 25 Feb 2021.
Charges
A charge registered on 30 Jul 2014 via Charge ID 10513388 with Hdfc Bank Limited was fully satisfied on 26 Feb 2018.
Charges
A charge with Others amounted to Rs. 3.02 Cr with Charge ID 100171676 was registered on 16 Nov 2017.
Charges
A charge with Hdfc Bank Limited of Rs. 2.40 Cr registered on 30 Jul 2014 with Charge ID 10513388 was modified on 27 Feb 2017.
Charges
A charge registered on 28 Dec 2005 via Charge ID 80013523 with State Bank Of India was fully satisfied on 18 Sep 2014.
Charges
A charge registered on 30 Mar 2011 via Charge ID 10275917 with Small Industrial Development Bank Of India was fully satisfied on 04 Sep 2014.
Charges
A charge registered on 29 Apr 2010 via Charge ID 10220460 with Small Industries Development Bank Of India was fully satisfied on 04 Sep 2014.
Charges
A charge registered on 13 Feb 2013 via Charge ID 10414270 with State Bank Of India was fully satisfied on 03 Sep 2014.
15 earlier events are in the company report.
Frequently asked questions
Cris Pharma (India) is an active public limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 September 1992 (34+ years old) and is registered under CIN U24139RJ1992PLC034757.
Cris Pharma (India) has 3 current directors:
- Poonam Chand Taparia - Whole-Time Director
- Kailash Chand Melana - Director
- Suwa Lal Jat - Director
The latest financial statements of Cris Pharma (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Cris Pharma (India) is 05AAACC8431A1ZB, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Cris Pharma (India) is U24139RJ1992PLC034757. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cris Pharma (India) has 7 court cases on record: 1 filed by the company and 6 filed against it. 2 are pending. Most are in the district courts.
Cris Pharma (India) was incorporated on 01 September 1992, making it 34+ years old. It is registered with the Registrar of Companies, Jaipur.
Rajnikant Chunilal Mehta ceased to be Director on 17 Apr 2023. Vinod Kalani ceased to be Director on 18 Oct 2013. Raspreet Singh ceased to be Whole-Time Director on 15 Sep 2011. Cris Pharma (India) has 8 board changes on record in total.
Yes, Cris Pharma (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-UK-05-0004318).
Cris Pharma (India) has 7 MSME Form 1 returns on record between 2019 and 2022, listing 279 overdue payments to 36 micro and small suppliers. The latest return was filed on 18 Aug 2022.
Cris Pharma (India) can be reached through the website crispharma.com. Its registered office is in Jaipur, Rajasthan, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages